Page 5 - Enzyme Immunoassay News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Enzyme immunoassay. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Enzyme Immunoassay Today - Breaking & Trending Today

DOST approves 6 R&D projects as part of VIP program – DOST chief – Manila Bulletin


DOST Secretary Fortunato “Boy” T. de la Peña (PCOO/Manila Bulletin File photo)
DOST Secretary Fortunato T. de la Peña announced Friday, May 28, that the agency “has approved for implementation” the new R&D projects of the DOST-Industrial Technology Development Institute (ITDI) as part of the VIP program.
These are the following:
-Combination Therapy: Lytic Bacteriophages and Plant Extracts against Multidrug-Resistant Bacteria;
-Detection of Food and Water-borne Bacterial Pathogens using Phage-based Diagnostics;
-De novo synthesis of a non-Infective Zika Pseudovirus as reference for diagnostics and vaccines development;
-Development of Antibody Test Kits for COVID-19 using Enzyme Immunoassay; and ....

De La Pe , Philippines General , Annabelle Briones , Maria Terresea Dimamay , Vlps Pseudoviruses , Catherine Masangkay , Zika Pseudovirus , Gelito Joseph Sikat , Ursela Bigol , Luke Medical Center , Research Institute Of Tropical Medicine , Technology Development Institute , Development Of Antibody Test Kits , Department Of Science , Vaccine Development , Technology Institute Of The Philippines , Biotechnology Division , Virology Science , Technology Institute , Industrial Technology Development Institute , Philippine Common Viruses , Medical Importance , Pandemic Potential , Antigen Antibody Studies , Combination Therapy , Lytic Bacteriophages ,

Enzyme Immunoassay (EIA) Reagents and Devices Market Growing Demand with Innovative Ideas Adopted by Key Players – Thermo Fisher Scientific Inc., BD, QIAGEN, Agilent Technologies, Inc – KSU


decisivemarketsinsightsMay 9, 2021
The
Enzyme Immunoassay (EIA) Reagents and Devices market is expected to grow at a CAGR of 6.7% and is poised to reach $XX Billion by 2027 as compared to $XX Billion in 2020. The factors leading to this extraordinary growth is attributed to various market dynamics discussed in the report. Our experts have examined the market from a 360 degree perspective thereby producing a report which is definitely going to impact your business decisions.
In order to make a pre-order inquiry, kindly click on the link below:-
Enzyme Immunoassay (EIA) Reagents and Devices Market Summary and Growth Forecast
The development of the industry in the national and the international markets is traced in the Enzyme Immunoassay (EIA) Reagents and Devices market research industry analysis report by Decisive Markets Insights on the global market. To make the business leaders or any market participants familiar with the markets and the different stages of ....

United States , Sunil Kumar , Agilent Technologies Inc , Roche Ltd , Phoenix Pharmaceuticals , Sysmex Corporation , Bio Rad Laboratories Inc , Merck Kga , Siemens Healthcare Private , Merck Kgaa , Thermo Fisher Scientific Inc , Key Companies , Hologic Inc , Promega Corporation , Enzyme Immunoassay , Devices Market Summary , Decisive Markets Insights , Decisive Markets , Sample Copy , Companies Operating , Agilent Technologies , Bio Rad Laboratories , Siemens Healthcare Private Limited , Neonatal Screening , End Users , Pharmaceutical Industries ,